Rocuronium-sugammadex use in electroconvulsive therapy of patients with pseudocholinesterase enzyme deficiency

J Clin Anesth. 2013 Dec;25(8):680-1. doi: 10.1016/j.jclinane.2013.07.008. Epub 2013 Oct 3.

Authors

Esra Yuksel¹, Demet Sergin², Burçak Tanatti², Işık Alper²

Affiliations

¹ Department of Anesthesiology and Reanimation, Ege University School of Medicine, Bornova, 35100 Izmir, Turkey. Electronic address: aecagiran@gmail.com.
² Department of Anesthesiology and Reanimation, Ege University School of Medicine, Bornova, 35100 Izmir, Turkey.

PMID: 24095888
DOI: 10.1016/j.jclinane.2013.07.008

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Androstanols*
Apnea
Butyrylcholinesterase / deficiency*
Contraindications
Electroconvulsive Therapy / methods*
Humans
Male
Metabolism, Inborn Errors / complications*
Middle Aged
Neuromuscular Nondepolarizing Agents*
Rocuronium
Succinylcholine
Sugammadex
gamma-Cyclodextrins*

Substances

Androstanols
Neuromuscular Nondepolarizing Agents
gamma-Cyclodextrins
Sugammadex
Butyrylcholinesterase
Succinylcholine
Rocuronium

Supplementary concepts

Butyrylcholinesterase deficiency